Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
P2.10 - Small Cell Lung Cancer and Neuro-endocrine Tumors
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors
-
+
P2.10-01 - Transcriptional Diversity of Emerging Cell Populations in Refractory Small Cell Lung Cancer Biopsies and Xenografts
Presenter: Allison Stewart- Abstract
Loading... -
+
P2.10-02 - EMERGE 402: Preliminary Real-world Characteristics and Safety of Lurbinectedin in Patients With Small-cell Lung Cancer
Presenter: Balazs Halmos- Abstract
Loading... -
+
P2.10-03 - High-dose Thoracic Radiotherapy Improves the Overall Survival of Oligo-Metastatic Extensive-Stage Small Cell Lung Cancer
Presenter: Zhengfei Zhu- Abstract
Loading... -
+
P2.10-04 - Immunologic Subtype of Small Cell Lung Carcinoma Dictates Susceptibility to NK Cell-Mediated Cytotoxicity
Presenter: Navin R Mahadevan- Abstract
Loading... -
+
P2.10-05 - Circulating CD3+CD56+ Cells as a Biomarker for Immunotherapy in SCLC.
Presenter: vito longo- Abstract
No abstract available for this presentation
-
+
P2.11 - Tobacco Control and Risk Reduction
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Tobacco Control and Risk Reduction
-
+
P2.11-01 - Awareness of Lung Cancer Risk Factors in Palestine: Current Situation and Future Directions
Presenter: Ahmad Mansour- Abstract
Loading... -
+
P2.11-02 - New Assay for Smoking Status based on 3D Imaging of Pulmonary Macrophages
Presenter: Michael G Meyer- Abstract
Loading... -
+
P2.11-03 - Smoking Prevention Intervention With School Classes in University Hospital by Thoracic Surgeon und Pulmonologist
Presenter: Sven Hillinger- Abstract
Loading...
-
+
P2.12 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
-
+
P2.12-01 - Intratumoral Conventional Type 1 Dendritic Cells (cDC1s) Predict Response to Immunotherapy in Human Non-small Cell Lung Cancer cancer (NSCLC)
Presenter: Angelo Porciuncula- Abstract
Loading... -
+
P2.12-02 - Immune-Cell Distribution Between Tumor Edge and Center Affects Lung Cancer Aggressiveness - Multiplex Immunofluorescence
Presenter: Takashi Eguchi- Abstract
Loading... -
+
P2.12-03 - External Validation of a Novel CT-Based Prognostic Radiomic Signature in Patients With Metastatic NSCLC in SWOG S0819 Phase III Randomized Trial
Presenter: Laurent Dercle- Abstract
Loading... -
+
P2.12-04 - The Role of Serum Proteomic Signature in Predicting Survival in PD-L1 Low Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor (ICI)
Presenter: YOUJIN OH- Abstract
Loading... -
+
P2.12-05 - Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes with PD-L1 Blockade to Reverse Type-2Mediated Immunosuppression
Presenter: Thomas Urban Marron- Abstract
Loading...
-
+
P2.13 - Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
-
+
P2.13-01 - Low EV miR-30c Levels as Biomarker of Increased Tumor Autophagy and Chemoradiotherapy Resistance in Locally Advanced NSCLC
Presenter: Diego de Miguel Perez- Abstract
Loading... -
+
P2.13-02 - Dynamic Tracking of Bespoke Circulating Tumour DNA During Multi-Modality Therapy for Locally Advanced NSCLC (LA-NSCLC)
Presenter: Kevin Lee Min Chua- Abstract
Loading... -
+
P2.13-03 - Plasma Profiling Unveils Transcriptional Signatures Associated with Resistance to Osimertinib in Non-Small Cell Lung Cancer
Presenter: Per Hydbring- Abstract
Loading...
-
+
P2.14 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
-
+
P2.14-01 - Clinical Utility of Reflex to Tissue-based Comprehensive Genomic Profiling (CGP) After Negative Liquid Biopsy (LBx) in NSCLC
Presenter: Khaled Tolba- Abstract
Loading... -
+
P2.14-02 - TP53 Mutations Affect Sensitivity to Lorlatinib in ROS1 Positive NSCLC: Final Results of the PFROST Trial
Presenter: Lorenza Landi- Abstract
Loading... -
+
P2.14-03 - Restored Ubiquitination and Degradation of Exon 14 Skipped MET with Proteolysis Targeting Chimeras
Presenter: Aaron Scott Mansfield- Abstract
Loading... -
+
P2.14-04 - Re-Definition of Lung Adenocarcinoma Transcriptional Subtypes Using Integrative Bioinformatics Approaches
Presenter: Sara Hijazo-Pechero- Abstract
Loading...
-
+
P2.15 - Tumor Biology and Biomarkers - Tumour Biology & Preclinical Studies
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Tumor Biology and Biomarkers - Tumour Biology & Preclinical Studies
-
+
P2.15-01 - Digital Pathology Uncovers Multi-Omic Hallmarks of Lung Cancer in Histopathology Images
Presenter: Maria Guramare- Abstract
Loading...
-
+
HOD03 - Highlights of the Day - Tuesday (On-Demand)
- 00:00 - 00:45
- 8/09/2022
- Location: On-Demand
- Not for CME Credit
- Type: Highlights of the Day
- Track: N/A
-
+
HOD03.01 - Surgery + Early Stage
12:00 - 12:15 | Presenter: Aki Katarina Kobayashi
- Abstract
Loading... -
+
HOD03.02 - Pathology + Epidemiology
12:15 - 12:30 | Presenter: Fernando Lopez-Rios
- Abstract
Loading... -
+
HOD03.03 - Medical Oncology
12:30 - 12:45 | Presenter: Alexander Drilon
- Abstract
Loading...
-
+
IBS13 - CNS Involvement in Oncogene-Driven and Not-Oncogene-Driven Disease: Optimal Management (Ticketed Session) (In-person Access Only)
- 07:30 - 08:15
- 8/09/2022
- Location: Lehar 1
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
IBS13.01 - CNS Involvement in Oncogene-Driven and Not-Oncogene-Driven Disease: Optimal Management
07:30 - 08:00 | Presenter: Rifaquat Rahman
- Abstract
Loading... -
+
IBS13.02 - Live Q&A
08:00 - 08:15
- Abstract
Loading...
-
+
IBS14 - Supportive Care in Lung Cancer: Improving Value in the Era of Modern Therapies (Ticketed Session)
- 07:30 - 08:15
- 8/09/2022
- Location:
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Palliative and Supportive Care
-
+
IBS15 - Should We Offer PCI and Consolidation Thoracic RT to Patients Treated with First-Line Chemo-Immunotherapy? (Ticketed Session) (In-person Access Only)
- 07:30 - 08:15
- 8/09/2022
- Location: Hall C8
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
-
+
IBS15.01 - No
07:30 - 07:45 | Presenter: Gyula Ostoros
- Abstract
Loading... -
+
IBS15.02 - Yes
07:45 - 08:00 | Presenter: Corinne Faivre-Finn
- Abstract
Loading... -
+
IBS15.03 - Live Q&A
08:00 - 08:15
- Abstract
Loading...
first
prev
